Related Experiment Video
Updated: Jul 19, 2026
06:58
A Behavioral Screen for Heat-Induced Seizures in Mouse Models of Epilepsy
Published on: July 12, 2021
Impaired inactivation gate stabilization predicts increased persistent current for an epilepsy-associated SCN1A
Kristopher M Kahlig1, Sunita N Misra, Alfred L George
1Division of Genetic Medicine, Department of Medicine, Vanderbilt University, Nashville, Tennessee 37232-0275, USA.
Summary
Computational modeling of SCN1A mutations reveals a two-step inactivation process. Impaired latching in this mechanism explains increased sodium current in genetic epilepsy, like GEFS+.
Area of Science:
- Neuroscience
- Computational Biology
- Genetics
Background:
- Mutations in SCN1A are linked to severe epilepsy syndromes such as GEFS+.
- These mutations often lead to an abnormal increase in persistent sodium current in neurons.
Purpose of the Study:
- To develop and utilize a computational model of SCN1A to understand the molecular basis of increased persistent sodium current in the GEFS+ R1648H mutant.
- To investigate the biophysical properties of SCN1A channels.
Main Methods:
- Formulation and application of a computational model for the SCN1A gene.
- Accurate reproduction of experimentally measured SCN1A whole-cell biophysical properties.
- Analysis of channel activation, inactivation, and recovery dynamics.
Main Results:
- The model successfully replicated SCN1A biophysical properties, including current decay, activation, and inactivation kinetics.
- A two-step open-state inactivation process was predicted: initial gate closure followed by stabilization via a 'latch' mechanism.
- Selective disruption of the latching step mimicked the increased persistent sodium current observed in the R1648H GEFS+ mutant.
Conclusions:
- The study provides a detailed molecular mechanism for SCN1A dysfunction in GEFS+.
- Computational modeling offers a powerful tool for studying abnormal neuronal activity in epilepsy.
- Findings may inform the development of targeted therapeutic strategies for SCN1A-related epilepsies.
More Related Videos
Related Concept Videos
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:19Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...